The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global BCG and Tuberculosis Vaccine Market Research Report 2025
Synopsis
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG and Tuberculosis Vaccine market was valued at US$ 76 million in 2023 and is anticipated to reach US$ 93 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
This report aims to provide a comprehensive presentation of the global market for BCG and Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG and Tuberculosis Vaccine.
Report Scope
The BCG and Tuberculosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG and Tuberculosis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG and Tuberculosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG and Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG and Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG and Tuberculosis Vaccine market was valued at US$ 76 million in 2023 and is anticipated to reach US$ 93 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
This report aims to provide a comprehensive presentation of the global market for BCG and Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG and Tuberculosis Vaccine.
Report Scope
The BCG and Tuberculosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG and Tuberculosis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG and Tuberculosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG and Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG and Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 BCG and Tuberculosis Vaccine Market Overview
1.1 Product Overview and Scope of BCG and Tuberculosis Vaccine
1.2 BCG and Tuberculosis Vaccine Segment by Type
1.2.1 Global BCG and Tuberculosis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 BCG and Tuberculosis Vaccine Segment by Application
1.3.1 Global BCG and Tuberculosis Vaccine Market Value by Application: (2024-2030)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Others
1.4 Global BCG and Tuberculosis Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG and Tuberculosis Vaccine Revenue 2019-2030
1.4.2 Global BCG and Tuberculosis Vaccine Sales 2019-2030
1.4.3 Global BCG and Tuberculosis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 BCG and Tuberculosis Vaccine Market Competition by Manufacturers
2.1 Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global BCG and Tuberculosis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global BCG and Tuberculosis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG and Tuberculosis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG and Tuberculosis Vaccine, Product Type & Application
2.7 BCG and Tuberculosis Vaccine Market Competitive Situation and Trends
2.7.1 BCG and Tuberculosis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BCG and Tuberculosis Vaccine Players Market Share by Revenue
2.7.3 Global BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG and Tuberculosis Vaccine Retrospective Market Scenario by Region
3.1 Global BCG and Tuberculosis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global BCG and Tuberculosis Vaccine Global BCG and Tuberculosis Vaccine Sales by Region: 2019-2030
3.2.1 Global BCG and Tuberculosis Vaccine Sales by Region: 2019-2024
3.2.2 Global BCG and Tuberculosis Vaccine Sales by Region: 2025-2030
3.3 Global BCG and Tuberculosis Vaccine Global BCG and Tuberculosis Vaccine Revenue by Region: 2019-2030
3.3.1 Global BCG and Tuberculosis Vaccine Revenue by Region: 2019-2024
3.3.2 Global BCG and Tuberculosis Vaccine Revenue by Region: 2025-2030
3.4 North America BCG and Tuberculosis Vaccine Market Facts & Figures by Country
3.4.1 North America BCG and Tuberculosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America BCG and Tuberculosis Vaccine Sales by Country (2019-2030)
3.4.3 North America BCG and Tuberculosis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe BCG and Tuberculosis Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG and Tuberculosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2030)
3.5.3 Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG and Tuberculosis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific BCG and Tuberculosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific BCG and Tuberculosis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific BCG and Tuberculosis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America BCG and Tuberculosis Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG and Tuberculosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America BCG and Tuberculosis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America BCG and Tuberculosis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG and Tuberculosis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global BCG and Tuberculosis Vaccine Sales by Type (2019-2030)
4.1.1 Global BCG and Tuberculosis Vaccine Sales by Type (2019-2024)
4.1.2 Global BCG and Tuberculosis Vaccine Sales by Type (2025-2030)
4.1.3 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global BCG and Tuberculosis Vaccine Revenue by Type (2019-2030)
4.2.1 Global BCG and Tuberculosis Vaccine Revenue by Type (2019-2024)
4.2.2 Global BCG and Tuberculosis Vaccine Revenue by Type (2025-2030)
4.2.3 Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global BCG and Tuberculosis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global BCG and Tuberculosis Vaccine Sales by Application (2019-2030)
5.1.1 Global BCG and Tuberculosis Vaccine Sales by Application (2019-2024)
5.1.2 Global BCG and Tuberculosis Vaccine Sales by Application (2025-2030)
5.1.3 Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global BCG and Tuberculosis Vaccine Revenue by Application (2019-2030)
5.2.1 Global BCG and Tuberculosis Vaccine Revenue by Application (2019-2024)
5.2.2 Global BCG and Tuberculosis Vaccine Revenue by Application (2025-2030)
5.2.3 Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global BCG and Tuberculosis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck BCG and Tuberculosis Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Japan BCG Lab BCG and Tuberculosis Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute of India BCG and Tuberculosis Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AJ Vaccines BCG and Tuberculosis Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioFarma BCG and Tuberculosis Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec BCG and Tuberculosis Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biomed Lublin BCG and Tuberculosis Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Corporation Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC-Institute of Vaccines and Medical Biologicals
6.11.1 IVAC-Institute of Vaccines and Medical Biologicals Corporation Information
6.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Description and Business Overview
6.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Portfolio
6.11.5 IVAC-Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Corporation Information
6.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Corporation Information
6.13.2 Microgen BCG and Tuberculosis Vaccine Description and Business Overview
6.13.3 Microgen BCG and Tuberculosis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Microgen BCG and Tuberculosis Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG and Tuberculosis Vaccine Industry Chain Analysis
7.2 BCG and Tuberculosis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG and Tuberculosis Vaccine Production Mode & Process
7.4 BCG and Tuberculosis Vaccine Sales and Marketing
7.4.1 BCG and Tuberculosis Vaccine Sales Channels
7.4.2 BCG and Tuberculosis Vaccine Distributors
7.5 BCG and Tuberculosis Vaccine Customers
8 BCG and Tuberculosis Vaccine Market Dynamics
8.1 BCG and Tuberculosis Vaccine Industry Trends
8.2 BCG and Tuberculosis Vaccine Market Drivers
8.3 BCG and Tuberculosis Vaccine Market Challenges
8.4 BCG and Tuberculosis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global BCG and Tuberculosis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global BCG and Tuberculosis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global BCG and Tuberculosis Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global BCG and Tuberculosis Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market BCG and Tuberculosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of BCG and Tuberculosis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG and Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG and Tuberculosis Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG and Tuberculosis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global BCG and Tuberculosis Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global BCG and Tuberculosis Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global BCG and Tuberculosis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global BCG and Tuberculosis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America BCG and Tuberculosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America BCG and Tuberculosis Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America BCG and Tuberculosis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe BCG and Tuberculosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe BCG and Tuberculosis Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe BCG and Tuberculosis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific BCG and Tuberculosis Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific BCG and Tuberculosis Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific BCG and Tuberculosis Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific BCG and Tuberculosis Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific BCG and Tuberculosis Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America BCG and Tuberculosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America BCG and Tuberculosis Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America BCG and Tuberculosis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global BCG and Tuberculosis Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global BCG and Tuberculosis Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global BCG and Tuberculosis Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global BCG and Tuberculosis Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck BCG and Tuberculosis Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Corporation Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Japan BCG Lab BCG and Tuberculosis Vaccine Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Serum Institute of India BCG and Tuberculosis Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Corporation Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AJ Vaccines BCG and Tuberculosis Vaccine Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Corporation Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioFarma BCG and Tuberculosis Vaccine Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Corporation Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Corporation Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. China National Biotec BCG and Tuberculosis Vaccine Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Corporation Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biomed Lublin BCG and Tuberculosis Vaccine Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Corporation Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. IVAC-Institute of Vaccines and Medical Biologicals Corporation Information
Table 121. IVAC-Institute of Vaccines and Medical Biologicals Description and Business Overview
Table 122. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product
Table 124. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments/Updates
Table 125. Queen Saovabha Mem. Inst Corporation Information
Table 126. Queen Saovabha Mem. Inst Description and Business Overview
Table 127. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product
Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 130. Microgen Corporation Information
Table 131. Microgen Description and Business Overview
Table 132. Microgen BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Microgen BCG and Tuberculosis Vaccine Product
Table 134. Microgen Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. BCG and Tuberculosis Vaccine Distributors List
Table 138. BCG and Tuberculosis Vaccine Customers List
Table 139. BCG and Tuberculosis Vaccine Market Trends
Table 140. BCG and Tuberculosis Vaccine Market Drivers
Table 141. BCG and Tuberculosis Vaccine Market Challenges
Table 142. BCG and Tuberculosis Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of BCG and Tuberculosis Vaccine
Figure 2. Global BCG and Tuberculosis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global BCG and Tuberculosis Vaccine Market Share by Type in 2023 & 2030
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global BCG and Tuberculosis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global BCG and Tuberculosis Vaccine Market Share by Application in 2023 & 2030
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Others
Figure 11. Global BCG and Tuberculosis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global BCG and Tuberculosis Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global BCG and Tuberculosis Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global BCG and Tuberculosis Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. BCG and Tuberculosis Vaccine Report Years Considered
Figure 16. BCG and Tuberculosis Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest BCG and Tuberculosis Vaccine Players: Market Share by Revenue in 2023
Figure 19. BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global BCG and Tuberculosis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific BCG and Tuberculosis Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific BCG and Tuberculosis Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E BCG and Tuberculosis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of BCG and Tuberculosis Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of BCG and Tuberculosis Vaccine by Type (2019-2030)
Figure 56. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of BCG and Tuberculosis Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of BCG and Tuberculosis Vaccine by Application (2019-2030)
Figure 59. Global BCG and Tuberculosis Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 60. BCG and Tuberculosis Vaccine Value Chain
Figure 61. BCG and Tuberculosis Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
